Mechanisms of peripheral tolerance to allergens

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 2, 2013, Pages 161-170

  Soyer, O U ^a,b,c   Akdis, M ^b,c   Ring, J ^c,d   Behrendt, H ^c,d   Crameri, R ^b   Lauener, R ^c,e   Akdis, C A ^b,c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c CHRISTINE KÜHNE CENTER FOR ALLERGY RESEARCH AND EDUCATION CK CARE   (Switzerland)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Hochgebirgsklinik Davos Wolfgang   (Switzerland)

Author keywords

allergy; dendritic cells; peripheral tolerance; T helper cells; T regulatory cells

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 35; TRANSFORMING GROWTH FACTOR BETA;

ALLERGENICITY; ALLERGIC DISEASE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL ACTIVATION; DEFENSE MECHANISM; DENDRITIC CELL; EOSINOPHIL; EPITHELIUM CELL; GENETIC PREDISPOSITION; HELPER CELL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TH22 CELL; TH9 CELL;

ALLERGENS; ANTIBODY FORMATION; B-LYMPHOCYTES, REGULATORY; CYTOKINES; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; INTERLEUKIN-10; PERIPHERAL TOLERANCE; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84872410479     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12085     Document Type: Review

References (102)

1. Akdis CA,. Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med 2012; 18: 736-749.
2. Akdis M, Akdis CA,. IgE class switching and cellular memory. Nat Immunol 2012; 13: 312-314.
3. Larche M, Akdis CA, Valenta R,. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 10: 761-771.
4. Breiteneder H, Mills EN,. Molecular properties of food allergens. J Allergy Clin Immunol 2005; 1: 14-23.
5. Ozdemir C, Akdis M, Akdis CA,. T-cell response to allergens. Chem Immunol Allergy 2010; 95: 22-44.
6. Kanzler H, Barrat FJ, Hessel EM, Coffman RL,. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007; 13: 552-559.
7. Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006; 355: 1445-1455.
8. Hessel EM, Chu M, Lizcano JO, Chang B, Herman N, Kell SA, et al. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J Exp Med 2005; 202: 1563-1573.
9. Novak N, Allam JP,. Mucosal dendritic cells in allergy and immunotherapy. Allergy 2011; 66 (Suppl 95): 22-24.
10. Hammad H, Lambrecht BN,. Dendritic cells and airway epithelial cells at the interface between innate and adaptive immune responses. Allergy 2011; 66: 579-587.
11. Fear VS, Burchell JT, Lai SP, Wikstrom ME, Blank F, von Garnier C, et al. Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T cell proliferation during the induction of inhalation tolerance. J Immunol 2011; 187: 4561-4570.
12. van Rijt LS, Vos N, Willart M, Muskens F, Tak PP, van der Horst C, et al. Persistent activation of dendritic cells after resolution of allergic airway inflammation breaks tolerance to inhaled allergens in mice. Am J Respir Crit Care Med 2011; 184: 303-311.
13. Azzaoui I, Yahia SA, Chang Y, Vorng H, Morales O, Fan Y, et al. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects. Blood 2011; 118: 3549-3558.
14. Lu M, Dawicki W, Zhang X, Huang H, Nayyar A, Gordon JR,. Therapeutic induction of tolerance by IL-10-differentiated dendritic cells in a mouse model of house dust mite-asthma. Allergy 2011; 66: 612-620.
15. Besnard AG, Togbe D, Guillou N, Erard F, Quesniaux V, Ryffel B,. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol 2011; 41: 1675-1686.
16. Zimmermann M, Koreck A, Meyer N, Basinski T, Meiler F, Simone B, et al. TNF-like weak inducer of apoptosis (TWEAK) and TNF-alpha cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol 2011; 127: 200-207.
17. Wang Y, Bi Y, Wu K, Wang C,. Dendritic cell co-transfected with FasL and allergen genes induces T cell tolerance and decreases airway inflammation in allergen induced murine model. Mol Biol Rep 2011; 38: 809-817.
18. Ehirchiou D, Xiong Y, Xu G, Chen W, Shi Y, Zhang L,. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J Exp Med 2007; 204: 1519-1524.
19. Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, Inaba K, et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol 2008; 181: 6923-6933.
20. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM,. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 2007; 8: 145-153.
21. Zhu J, Cote-Sierra J, Guo L, Paul WE,. Stat5 activation plays a critical role in Th2 differentiation. Immunity 2003; 19: 739-748.
22. Mantel PY, Kuipers H, Boyman O, Rhyner C, Ouaked N, Ruckert B, et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 2007; 5: e329.
23. Bullens DM, Van Den Keybus C, Dilissen E, Kasran A, Ceuppens JL,. Allergen-specific T cells from birch-pollen-allergic patients and healthy controls differ in T helper 2 cytokine and in interleukin-10 production. Clin Exp Allergy 2004; 34: 879-887.
24. Kimura M, Tsuruta S, Yoshida T,. IL-4 production by PBMCs on stimulation with mite allergen is correlated with the level of serum IgE antibody against mite in children with bronchial asthma. J Allergy Clin Immunol 2000; 105 (2 Pt 1): 327-332.
25. Noma T, Sugawara Y, Ogawa N, Saeki T, Yamaguchi K, Kawano Y,. Dermatophagoides-induced interleukin-10 production by peripheral blood lymphocytes from patients with asthma in remission. Pediatr Allergy Immunol 2004; 15: 459-468.
26. Zhao CQ, Li TL, He SH, Chen X, An YF, Wu WK, et al. Specific immunotherapy suppresses Th2 responses via modulating TIM1/TIM4 interaction on dendritic cells. Allergy 2010; 65: 986-995.
27. Lee J, Phong B, Egloff AM, Kane LP,. TIM polymorphisms-genetics and function. Genes Immun 2011; 12: 595-604.
28. Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M, Travis M, et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001; 167: 336-343.
29. Kashyap M, Rochman Y, Spolski R, Samsel L, Leonard WJ,. Thymic stromal lymphopoietin is produced by dendritic cells. J Immunol 2011; 187: 1207-1211.
30. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-680.
31. Lei L, Zhang Y, Yao W, Kaplan MH, Zhou B,. Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells. J Immunol 2011; 186: 2254-2261.
32. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174: 8183-8190.
33. Hunninghake GM, Soto-Quiros ME, Avila L, Kim HP, Lasky-Su J, Rafaels N, et al. TSLP polymorphisms are associated with asthma in a sex-specific fashion. Allergy 2010; 65: 1566-1575.
34. Akdis M, Palomares O, van de Veen W, van Splunter M, Akdis CA,. T(H)17 and T(H)22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol 2012; 129: 1438-1449.
35. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121-1133.
36. Burgler S, Mantel PY, Bassin C, Ouaked N, Akdis CA, Schmidt-Weber CB,. RORC2 is involved in T cell polarization through interaction with the FOXP3 promoter. J Immunol 2010; 184: 6161-6169.
37. Sergejeva S, Ivanov S, Lotvall J, Linden A,. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Respir Cell Mol Biol 2005; 33: 248-253.
38. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008; 9: 1347-1355.
39. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008; 9: 1341-1346.
40. Goswami R, Jabeen R, Yagi R, Pham D, Zhu J, Goenka S, et al. STAT6-dependent regulation of Th9 development. J Immunol 2012; 188: 968-975.
41. Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010; 33: 192-202.
42. Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A, et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 2003; 111: 1319-1327.
43. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011; 127: 701-721.
44. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009; 119: 3573-3585.
45. Takahashi K, Hirose K, Kawashima S, Niwa Y, Wakashin H, Iwata A, et al. IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J Allergy Clin Immunol 2011; 128: 1067-1076.
46. Akdis M,. Immune tolerance in allergy. Curr Opin Immunol 2009; 21: 700-707.
47. Toda A, Piccirillo CA,. Development and function of naturally occurring CD4+CD25+ regulatory T cells. J Leukoc Biol 2006; 80: 458-470.
48. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-1214.
49. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M,. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008; 205: 2887-2898.
50. Meiler F, Klunker S, Zimmermann M, Akdis CA, Akdis M,. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 2008; 63: 1455-1463.
51. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199: 1567-1575.
52. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-440.
53. Jaffar Z, Ferrini ME, Girtsman TA, Roberts K,. Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol 2009; 39: 3307-3314.
54. Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, et al. CD4+ CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008; 29: 771-781.
55. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S,. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. PNAS 2008; 105: 10113-10118.
56. Nguyen KD, Vanichsarn C, Nadeau KC,. Impaired IL-10-dependent induction of tolerogenic dendritic cells by CD4+ CD25hiCD127lo/- natural regulatory T cells in human allergic asthma. Am J Respir Crit Care Med 2009; 180: 823-833.
57. Lewkowich IP, Herman NS, Schleifer KW, Dance MP, Chen BL, Dienger KM, et al. CD4+ CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 2005; 202: 1549-1561.
58. Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF, et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006; 117: 176-183.
59. Mamessier E, Nieves A, Lorec AM, Dupuy P, Pinot D, Pinet C, et al. T-cell activation during exacerbations: a longitudinal study in refractory asthma. Allergy 2008; 63: 1202-1210.
60. Smyth LJ, Eustace A, Kolsum U, Blaikely J, Singh D,. Increased airway T regulatory cells in asthmatic subjects. Chest 2010; 138: 905-912.
61. Lin YL, Shieh CC, Wang JY,. The functional insufficiency of human CD4+ CD25 high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation. Allergy 2008; 63: 67-74.
62. Domdey A, Liu A, Millner A, Lund K, Jacobi H, Malling HJ, et al. The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects. Int Arch Allergy Immunol 2010; 152: 243-254.
63. Burchell JT, Wikstrom ME, Stumbles PA, Sly PD, Turner DJ,. Attenuation of allergen-induced airway hyperresponsiveness is mediated by airway regulatory T cells. Am J Physiol Lung Cell Mol Physiol 2009; 296: L307-L319.
64. Mittag D, Scholzen A, Varese N, Baxter L, Paukovics G, Harrison LC, et al. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells. J Immunol 2010; 184: 4708-4716.
65. Nguyen KD, Vanichsarn C, Fohner A, Nadeau KC,. Selective deregulation in chemokine signaling pathways of CD4+ CD25(hi)CD127(lo)/(-) regulatory T cells in human allergic asthma. J Allergy Clin Immunol 2009; 123: 933-939.
66. Karlsson MR, Rugtveit J, Brandtzaeg P,. Allergen-responsive CD4+ CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004; 199: 1679-1688.
67. Shreffler WG, Wanich N, Moloney M, Nowak-Wegrzyn A, Sampson HA,. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 2009; 123: 43-52.
68. Palomares O, Ruckert B, Jartti T, Kucuksezer UC, Puhakka T, Gomez E, et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol 2012; 129: 510-520.
69. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM,. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3: 944-950.
70. Mauri C, Gray D, Mushtaq N, Londei M,. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003; 197: 489-501.
71. Noh J, Lee JH, Noh G, Bang SY, Kim HS, Choi WS, et al. Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br1) in Cow Milk Allergy. Cell Immunol 2010; 264: 143-149.
72. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG,. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 2010; 125: 1114-1124.
73. Hussaarts L, van der Vlugt LE, Yazdanbakhsh M, Smits HH,. Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 2011; 128: 733-739.
74. Suzuki M, Zheng X, Zhang X, Ichim TE, Sun H, Kubo N, et al. Inhibition of allergic responses by CD40 gene silencing. Allergy 2009; 64: 387-397.
75. Turcanu V, Winterbotham M, Kelleher P, Lack G,. Peanut-specific B and T cell responses are correlated in peanut-allergic but not in non-allergic individuals. Clin Exp Allergy 2008; 38: 1132-1139.
76. Jutel M, Akdis M, Akdis CA,. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 2009; 39: 1786-1800.
77. Pereira EA, Silva DA, Cunha-Junior JP, Almeida KC, Alves R, Sung SJ, et al. IgE, IgG1, and IgG4 antibody responses to Blomia tropicalis in atopic patients. Allergy 2005; 60: 401-406.
78. Uermosi C, Beerli RR, Bauer M, Manolova V, Dietmeier K, Buser RB, et al. Mechanisms of allergen-specific desensitization. J Allergy Clin Immunol 2010; 126: 375-383.
79. Schroeder HW Jr, Cavacini L,. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010; 125 (2 Suppl 2): S41-S52.
80. Aalberse RC, Stapel SO, Schuurman J, Rispens T,. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009; 39: 469-477.
81. Shamji MH, Ljorring C, Francis JN, Calderon MA, Larché M, Kimber I, et al. Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy 2012; 67: 217-226.
82. Sin BA, Akdis M, Zumkehr J, Bezzine S, Bekpen C, Lambeau G, et al. T-cell and antibody responses to phospholipase A2 from different species show distinct cross-reactivity patterns. Allergy 2011; 66: 1513-1521.
83. Akdis CA, Akdis M,. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127: 18-27.
84. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K,. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
85. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S,. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353-360.
86. Baecher-Allan C, Viglietta V, Hafler DA,. Human CD4+ CD25+ regulatory T cells. Semin Immunol 2004; 16: 89-98.
87. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008; 28: 870-880.
88. Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglio M, Magnani CF, et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010; 116: 935-944.
89. Kennedy Norton S, Barnstein B, Brenzovich J, Bailey DP, Kashyap M, Speiran K, et al. IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo. J Immunol 2008; 180: 2848-2854.
90. Kearley J, Barker JE, Robinson DS, Lloyd CM,. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 2005; 202: 1539-1547.
91. Yoshimura A, Wakabayashi Y, Mori T,. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem 2010; 147: 781-792.
92. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+ CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886.
93. Klunker S, Chong MM, Mantel PY, Palomares O, Bassin C, Ziegler M, et al. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med 2009; 206: 2701-2715.
94. Gorelik L, Constant S, Flavell RA,. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 2002; 195: 1499-1505.
95. Gorelik L, Fields PE, Flavell RA,. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 2000; 165: 4773-4777.
96. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010; 11: 1093-1101.
97. Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA,. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2011; 186: 6661-6666.
98. Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN,. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 2012; 129: 207-215.
99. Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, Lee BW, et al. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 2011; 187: 462-471.
100. Meyer N, Christoph J, Makrinioti H, Indermitte P, Rhyner C, Soyka M, et al. Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol 2012; 129: 964-973.
101. Agache I, Akdis C, Jutel M, Virchow JC,. Untangling asthma phenotypes and endotypes. Allergy 2012; 67: 835-846.
102. Akdis C, Papadopoulos N, Cardona V,. Fighting allergies beyond symptoms: the European declaration on immunotherapy. Eur J Immunol 2011; 41: 2802-2804.